These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1435 related articles for article (PubMed ID: 15500907)

  • 1. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
    Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
    Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of therapeutics to the central nervous system.
    Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
    [No Abstract]   [Full Text] [Related]  

  • 8. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
    Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
    CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal drug delivery to the central nervous system: present status and future outlook.
    Tayebati SK; Nwankwo IE; Amenta F
    Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA
    Biopolymers; 2008; 90(5):589-94. PubMed ID: 18335425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.